Well I was buying RIETs in 2007 and then goldies in 2008 made an absolute killing on both while everybody was crying in their beer .
Then got a biotech that was another Disallowed
People are not going to stop getting cancer , we have a product that will probably be low cost to produce compared to any competition , as we do not have to support the P in the PE ratio as associated with a high market cap company
Bit of a slam dunk at 0.14 or $1.40
NRT Price at posting:
14.0¢ Sentiment: Buy Disclosure: Held